GlobalView

Ackland, Stephen P.

Statistics
Title Hits Visitors Downloads
A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients 94 87 0
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study 110 105 0
Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines 97 91 0
Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity 158 151 0
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer 60 48 0
Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas 141 137 0
Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition 146 132 0
Heterocyclic substituted cantharidin and norcantharidin analogues-synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity 208 189 0
Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect 72 60 0
Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer 120 109 0
Nab-paclitaxel: a bright new SPARC in taxane therapy of cancer (editorial) 169 159 0
Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition 93 88 0
Norcantharimides, synthesis and anticancer activity: synthesis of new norcantharidin analogues and their anticancer evaluation 136 123 0
Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A 129 114 0
Repository Search URL

Ackland, Stephen P.

Formatted Bibliography URL

Ackland, Stephen P.

Bibliography Markup

To include a live feed of this author's bibliography on a static Web page (e.g., a personal home page), add the following HTML code to the body of your HTML.